Thomas Courant

Plan, GR 1228, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.

Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.

Journal: Vaccine
Published: July 30, 2025

Correction: Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccine.

Correction: Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccine.

Journal: Frontiers in cellular and infection microbiology
Published: June 29, 2025

Ex vivo model of functioning human lymph node reveals role for innate lymphocytes and stroma in response to vaccine adjuvant.

Ex vivo model of functioning human lymph node reveals role for innate lymphocytes and stroma in response to vaccine adjuvant.

Journal: Cell reports
Published: November 06, 2024

An adjuvanted chimeric spike antigen boosts lung-resident memory T-cells and induces pan-sarbecovirus protective immunity.

An adjuvanted chimeric spike antigen boosts lung-resident memory T-cells and induces pan-sarbecovirus protective immunity.

Journal: NPJ vaccines
Published: October 19, 2024

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern.

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern.

Journal: Vaccine
Published: April 09, 2024

OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model.

OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model.

Journal: Frontiers in immunology
Published: March 17, 2023

Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines.

Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines.

Journal: Pharmacological research
Published: August 23, 2022

Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit Vaccine.

Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit Vaccine.

Journal: Frontiers in cellular and infection microbiology
Published: April 12, 2022

Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.

Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 21, 2021

Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters.

Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters.

Journal: bioRxiv : the preprint server for biology
Published: March 10, 2021

Characterization of Collagen/Lipid Nanoparticle-Curcumin Cryostructurates for Wound Healing Applications.

Characterization of Collagen/Lipid Nanoparticle-Curcumin Cryostructurates for Wound Healing Applications.

Journal: Macromolecular bioscience
Published: November 21, 2018

Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates.

Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates.

Journal: NPJ vaccines
Published: November 30, 2017
Showing 1-12 of 14

Last Updated: 09/26/2026